clinical trial · NCT05666960
R-3750 in Patients With Mild to Moderate Ulcerative Colitis
Ulcerative Colitis Chronic MildUlcerative Colitis Chronic ModerateUlcerative Colitis ChronicUlcerative ColitisR-3750
brief summary
The goal of this study is to determine the safety and tolerability of orally taken probiotic (R-3750) in patients with mild to moderate ulcerative colitis. Patients will take an oral dosage of probiotic (R-3750) and provide patient-reported and physician scored measures of their colitis. Blood and fecal evaluations of inflammation and assessment of probiotic (R-3750) on fecal levels will also be measured.
started
Feb 27, 2023
primary completion
Jul 1, 2026
completion
Oct 1, 2026
last updated
Jan 29, 2026
official title
A Single and Repeat Dosing Study of the Safety, Drug Exposure, and Clinical Activity of R-3750 in Patients With Mild to Moderate Ulcerative Colitis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol